D.A. Davidson & Co. Lantheus Holdings, Inc. Transaction History

D.A. Davidson & Co.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$51.07 - $68.26 $242,991 - $324,781	4,758 Added 61.95%	12,438 $774,000
Q4 2023 Feb 09, 2024	BUY	$55.6 - $77.89 $427,008 - $598,195	7,680 New	7,680 $476,000
Q2 2023 Aug 10, 2023	BUY	$82.41 - $99.65 $32,222 - $38,963	391 Added 2.83%	14,219 $1.19 Million
Q1 2023 Apr 25, 2023	SELL	$47.76 - $82.86 $11,223 - $19,472	-235 Reduced 1.67%	13,828 $1.14 Million
Q4 2022 Feb 03, 2023	BUY	$48.76 - $77.67 $145,109 - $231,145	2,976 Added 26.84%	14,063 $716,000
Q3 2022 Nov 07, 2022	BUY	$61.42 - $86.29 $353,287 - $496,340	5,752 Added 107.82%	11,087 $780,000
Q2 2022 Jul 28, 2022	BUY	$55.54 - $72.65 $296,305 - $387,587	5,335 New	5,335 $352,000

542

68M

679K

423K

Ticker LNTH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 68,741,904
Market Cap $6.29B
Description
Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for n...

Get notified when there are updates to the investment portfolio of D.A. Davidson & Co., based on Form 13F filings with the SEC.

Stay updated on D.A. Davidson & Co. with notifications on news.